Targeted drug delivery remains a major challenge in the treatment of colorectal cancer (CRC), particularly in overcoming tumor immune evasion. Exosome-based nanocarriers have shown considerable promise due to their tumor-targeting capability and immunomodulato... ...

请注册登录后继续浏览